Drug Profile
Glemanserin
Alternative Names: MDL 11939; MDL 11939ALatest Information Update: 04 Apr 1995
Price :
$50
*
At a glance
- Originator Aventis
- Class Antiglaucomas; Anxiolytics; Small molecules
- Mechanism of Action Potassium channel antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Arrhythmias